OSI Systems heads into its October 23 earnings report with short sellers quietly adding pressure and the stock nursing a 7% loss over the past month.
Short interest is the central tension here. Bears have added roughly 10% to their positions over the past 30 days, bringing short interest to 12.4% of the free float, a meaningfully elevated level for a mid-cap defense and security electronics name. The one-week build of 2.6% shows the move is still in progress, not unwinding. Days to cover stand at 8.23, per FINRA's latest fortnightly report, meaning any reversal would take bears more than a week and a half to exit at normal volumes. The ORTEX short score has hovered in the 68 to 70 range all month, registering in the 3rd percentile of the universe on that measure, an unusually bearish positioning rank. What keeps this from looking like a squeeze setup is the borrow market: availability is ample at 225%, well above the 52-week floor of 142%, and the cost to borrow is just 0.51%. There is no friction for new short sellers entering the trade.
Options positioning reinforces the picture but with a twist. The put/call ratio at 0.11 is actually below its 20-day average of 0.12, running about 1.3 standard deviations light on put demand. That means the options market is not rushing to hedge, even as short interest grows. The combination is unusual: shorts are building conviction, but options traders are not paying up for downside protection ahead of the print. One reading is that the short side is expressing a view through stock borrows rather than through the options market.
The Street remains broadly bullish, but the direction of travel on targets is uniformly downward. Following the most recent quarterly results in late August, B. Riley cut its target from $320 to $265 while keeping a Buy rating, and Oppenheimer trimmed from $320 to $300 maintaining Outperform. B of A Securities lowered to $300 back in July. The consensus mean target of $281 implies roughly 46% upside from the current $192.30 price, a gap that reflects either genuine undervaluation or targets that have not caught up to deteriorating sentiment. The PE stands at 15.5 times trailing earnings, down about 1.2 points over 30 days, and EV/EBITDA sits near 10.9 times. On forward earnings momentum the picture is more constructive: the 12-month forward EPS growth factor ranks in the 91st percentile of the universe, suggesting the Street still sees a strong earnings ramp ahead. The EV/EBIT factor ranks in the 69th percentile, not cheap but not stretched.
Institutional flows offer a useful footnote. BlackRock is the largest holder at 16% of shares, adding modestly in August. FMR (Fidelity) holds 10.9% but trimmed its 13G filing from 12.6% to 10.8% earlier this year, a reduction worth noting. Janus Henderson crossed above the 5% threshold in August, moving from 4.7% to 5.5%, a meaningful addition. No 13D activists are on the register. The insider picture from August 24 is primarily compensation mechanics: the CEO received a grant of 20,073 shares offset by a tax withholding disposal of 19,986 shares, a net retention of just 87 shares. The General Counsel activity followed the same grant-and-withhold pattern. None of these constitute open-market conviction buying.
The earnings history gives context for what October 23 could bring. The last print, in late August, produced a one-day decline of 6.4% and a five-day loss of 4.5%. The prior result followed an almost identical pattern. Two consecutive earnings drops of that magnitude help explain why short interest has climbed ahead of the next release rather than faded.
With the next print 23 days away, the numbers to watch are whether short interest continues to build through the October expiry cycle, whether borrow availability tightens as the event draws closer, and whether the forward earnings upgrade momentum that underpins the bull case shows up in pre-announcement signals or revisions.
See the live data behind this article on ORTEX.
Open OSIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
